Stocks making the biggest moves after hours: Chegg, Clorox, Avis and more

Market Insider

In this article

James Tahaney loads textbooks on to a pallet in preparation for shipping at the Chegg warehouse in Shepherdsville, Kentucky, April 29, 2010.
John Sommers II | Bloomberg | Getty Images

Check out the companies making headlines after the bell

Chegg — Shares of Chegg sunk more than 25% in extended trading after a weaker-than-expected quarterly report. The education technology company reported revenue of $171.9 million versus $174.5 million estimated, according to Refinitiv. Chegg also missed subscriber estimates.

Clorox — Clorox shares rose over 5% after hours following an earnings beat. The consumer products company reported an adjusted profit of $1.21 per share on revenue of $1.81 billion. Analysts expected earnings of $1.03 per share on revenue of $1.70 billion, according to Refinitiv.

Avis Budget Group — Shares of Avis Budget Group rose nearly 5% in after-hours trading following a strong third-quarter earnings report. The parent company of car rental brands reported adjusted earnings per share of $10.74, much higher than the Refinitiv consensus of $6.52 per share. Revenue came in higher-than-expected at $3 billion versus $2.715 billion estimated. Avis also announced a $1 billion increase to the company’s existing share repurchase authorization.

NXP Semiconductors — NXP Semiconductors shares whipsawed during extended trading after reporting a slight quarterly revenue beat. The chipmaker reported revenue of $2.86 billion, while analysts expected revenue of $2.85 billion, according to Refinitiv.

Simon Property Group — Simon Property Group shares gained 3% in extended trading after the mall owner beat earnings expectations soundly. The company reported earnings of $2.07 per share versus $1.09 per share expected by analysts surveyed by Refinitv. The company’s revenue also came in higher than expected.

Articles You May Like

Apple Intelligence: Redefining AI With the Ultimate Assistant
Op-ed: Here’s why a sale of Bausch + Lomb could lead to a windfall for Bausch Health investors
Point72’s Steve Cohen is stepping back from trading his own book
Rate Cuts to Energize Markets, Score Investors Tremendous Profits
Your favorite stocks may soon be quoted in half-penny increments – which could cut trading costs